Upcoming Webinars

Identification of unknown extractables and leachables using mass spectrometry: Identification with confidence?

Presented by Petra Booij, Investigator at GlaxoSmithKline and Dr Kyle D’Silva, Pharma & BioPharma Marketing Leader, Thermo Fisher Scientific
30th January 2020


Identification of Approaches to Simulated Leachable Studies: What are They? When to do Them?

Presented by Jason Creasey, Managing Director at Maven E&L Ltd and Karen Pieters, Ir. Team Leader Extractables and Leachables at Nelson Labs Europe
03rd February 2020


mAb Industry in China : Biosimilars vs Innovative Biologics

Presented by Dr. Joe X Zhou, CEO at Genor Biopharma, Walvax Bio Group and Sarah (Xuyu) Wang, Head of Segment Marketing, Biosimilars and Bioconjugations at Sartorius Stedim Biotech
10th February 2020


High-Resolution Characterization of Structure, Interaction, and Miscibility of Drug Products

Presented by Eric Munson, PhD, Professor and Head at Purdue University
11th February 2020


MES – Integrating Technology, Quality and Compliance – Opportunities, Challenges and Strategies.

Presented by Sachin Bhandari, GM, Head IT CSV at Sun Pharma
18th February 2020


Sampling Devices for In-line near Infrared Spectroscopy Monitoring of Powder Blend Homogeneity in Continuous Manufacturing

Presented by Anders Sparén, Associate Principal Scientist at AstraZeneca and Ed Gooding, MicroNIR Photonic Applications Specialist at VIAVI Solutions
03rd March 2020


Real-time Sequencing by FTIR in GMP Oligonucleotide Synthesis

Presented by John-David McElderry, Scientist at Biogen
04th March 2020


Harnessing the Power of Data Analytics to Derive Process Intelligence for Pharma Manufacturing

Presented by Santosh Whatkar, Senior Manager, Automation and Digital Technology at Pfizer
05th March 2020


Antisense Oligonucleotide Purification Process: Successes and Challenges During Scale-up

Presented by Robert Gronke, Ph.D., Senior Principal Scientist, Technical Development, Biogen and Thomas Müller-Späth, Ph.D, CTO at YMC ChromaCon
10th March 2020


In Situ High Speed NIR Imaging & Raman Mapping to Monitor Form Change and Drug Release from Rapidly Disintegrating Tablets

Presented by Patrick Wray, Senior Research Investigator at Bristol-Myers Squibb and Miriam Böhmler, Senior Applications Scientist at WITec GmbH
10th March 2020


Mitigating Uncertain Times: Challenges with Rapid Detection and Characterization of Biological and Chemical Threats and Accelerated Development of Pharmaceutical Countermeasures for Unanticipated Medical Needs

Presented by Douglas E. Kiehl, Research Advisor, Bioproduct, Research & Development at Eli Lily and Company
13th March 2020


The Journey Of Implementing Advanced Process Control In the Pharmaceutical Industry

Presented by Olav Lyngberg, PhD, Sr. Scientific Fellow, Advanced Technology Center of Excellence, Technical Operations, Janssen Pharmaceuticals
16th March 2020


IIoT and AI for Digitalizing Pharmaceutical Manufacturing Operations: From Hype to Reality

Presented by Jun Huang, Director/Team Leader, Process Monitoring, Automation & Control at Pfizer and Amos Dor, Pharma General Manager & CTO at Applied Materials Automation Product Group
17th March 2020


Extractable Data Mining: Common Extractables From Polymeric Manufacturing Materials Used in Biologics Production

Presented by Ping Wang, Director at Johnson & Johnson and Donald F. DeCou, Ph.D, Extractables and Leachables Technology Manager at West Pharmaceutical Services
23rd March 2020


Control Strategy and a Real Time Release Testing From a Development Line to Commercial Manufacturing

Presented by Tom Van Den Kerkhof Scientist at Johnson & Johnson
25th March 2020


Advanced Raman Spectroscopy Beyond In-Process Glucose Control of Commercial Cell Culture Processes

Presented by Dan Hill, Manufacturing Scientist at Biogen and Maryann Cuellar, Life Science Product Manager at Kaiser Optical Systems, Inc.
02nd April 2020


New Technologies for Improving and Controlling Product Quality, Expression, Timelines and Yield in Upstream Process Development

Presented by Niki Wong, Principal Research Scientist at AbbVie Operations Singapore Pte Ltd
07th April 2020


Assessing the Risk of Interaction Between Extractables and Leachable and Therapeutic Proteins

Presented by Andrew Teasdale, Senior Principal Scientist Impurity management and External Advocacy at AstraZeneca
08th April 2020


Transformation of Toxicology data into Specific PDE’s

Presented by Kim Li, PhD, DABT, MPH, Amgen Inc and Dries Cardoen, Team Leader of Study Directors at Nelson Laboratories, LLC
23rd April 2020


New Drying Processes for Biopharmaceuticals

Presented by Sune Klint Andersen, Principal Scientist at Janssen Pharmaceutical Companies of Johnson & Johnson
05th May 2020


Machine Learning in Bioprocess Development: Where We Are and Where We Could Go

Presented by Moritz von Stosch, PhD, Senior Manager, Technical R&D, GlaxoSmithKline Vaccines and Klaus Mauch, CEO at Insilico Biotechnology AG
06th May 2020


Next Frontier in Subvisible Particle Analysis: New Tools and Opportunities

Presented by Danny Chou, President and Founder at Compassion BioSolution, LLC and Mark Bumiller, Technology Manager at Particle Sizing Systems, an Entegris Company
07th May 2020


Affinity Chromatography for Vaccines Purification

Presented by Mikkel Nissum, Vaccine R&D Quality Site Lead at GSK Vaccines
12th May 2020


Continuous Manufacturing as a Default Platform for Oral Solid Drug Products

Presented by Lawrence De Belder, Senior Principal Engineer Continuous Manufacturing at Johnson and Johnson and Bob Lenich, Director of Life Sciences Business at Emerson
19th May 2020


Single-Use Bioprocess Platform for Veterinary Vaccine and Biopharmaceutical Pilot-Scale Production

Presented by Francis Verhoeye, Global Pilot Operations Leader at Zoetis Inc.
11th June 2020


Utility of Generating <665> Data: Drug Manufacture’s Perspective: Will USP permit such format?

Presented by Ken Wong, Deputy Director at Sanofi Pasteur and Desmond G. Hunt, Principal Liaison at United States Pharmacopeia
23rd June 2020


Rapid Microbial Methods – Reap Benefits And Avoiding Pitfalls

Presented by Dr Andrew Bartko, Research Leader at Battelle Memorial Institute
13th July 2020


Fully Utilizing Closed Systems in Modern BioPharma Facilities

Presented by Lars Hovmand-Lyster, Senior Engineering Specialist in Novo Nordisk Global Project Office (GPO) Engineering Management Department
03rd September 2020


Quantification and Control of Amorphous contents by Raman, Application and Case Studies in Pharmaceutical Processing

Presented by Michelle Raikes, M.S., Scientist IV and Dr. Fredrik Nordstrom, Sr Research Fellow at Boehringer Ingelheim
04th September 2020


Global Sterile Transportation and Formulation of an Adjuvant

Presented by Charlotte Masy, Project Manager in global support GSK vaccinés and Donald Young, Sr. Product Manager at Thermo Fisher Scientific
08th September 2020


Extractables and Leachables Testing Using a Quality Risk Management Approach

Presented by Dhaval Tapiawala, Principal Scientist at Pfizer
09th September 2020


From Concept to Market – Unique Approaches in Biomanufacturing

Presented by Jincai Li, Vice President of WuXi Biologics
11th September 2020


Strategies to Overcome Low Endotoxin Recovery Using the Conventional LAL Assay

Presented by Dr. Ruth Daniels, Senior Scientist - Microbiology Expert at Janssen
28th September 2020


Crystallization Monitoring of Active Pharmaceutical Ingredient By Raman Spectroscopy

Presented by John-David McElderry, Scientist at Biogen and Maryann Cuellar, Life Science Product Manager at Kaiser Optical Systems, Inc.
07th October 2020


Hybrid Models: The Best of Both (Mechanistic & Empirical) Worlds to Accelerate and De-Risk Process Development

Presented by Christian Airiau, PhD, Global Head Data Sciences, Biologics Development at Sanofi
12th October 2020


Establishing Early Development Strategies For Therapeutics Proteins

Presented by Thorsten Lorenz, Head Early Drug Substance Development at Novartis
21st October 2020